<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diabetic conditions are associated with modified brain function, namely with <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo>, through largely undetermined processes </plain></SENT>
<SENT sid="1" pm="."><plain>More than understanding the underlying mechanism, it is important to devise novel strategies to alleviate <z:mp ids='MP_0002055'>diabetes</z:mp>-induced <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="111" ids="27732">Caffeine</z:chebi> (a mixed <z:chebi fb="68" ids="48706">antagonist</z:chebi> of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A(1) and A(2A) receptors) emerges as a promising candidate since <z:chebi fb="111" ids="27732">caffeine</z:chebi> consumption reduces the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> and effectively prevents <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> caused by different noxious stimuli </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we took advantage of a novel animal model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to investigate the behavioural, neurochemical and morphological modifications present in the hippocampus and tested if <z:chebi fb="111" ids="27732">caffeine</z:chebi> consumption might prevent these changes </plain></SENT>
<SENT sid="4" pm="."><plain>We used a model closely mimicking the human type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> condition, NONcNZO10/LtJ mice, which become diabetic at 7-11 months when kept under an 11% fat diet </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="111" ids="27732">Caffeine</z:chebi> (1 g/l) was applied in the drinking water from 7 months onwards </plain></SENT>
<SENT sid="6" pm="."><plain>Diabetic mice displayed a decreased spontaneous alternation in the Y-maze accompanied by a decreased density of nerve terminal markers (synaptophysin, SNAP25), mainly glutamatergic (vesicular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporters), and increased <z:mp ids='MP_0003354'>astrogliosis</z:mp> (GFAP immunoreactivity) compared to their <z:mp ids='MP_0002169'>wild type</z:mp> littermates kept under the same diet </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, diabetic mice displayed up-regulated A(2A) receptors and down-regulated A(1) receptors in the hippocampus </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="111" ids="27732">Caffeine</z:chebi> consumption restored memory performance and abrogated the <z:mp ids='MP_0002055'>diabetes</z:mp>-induced loss of nerve terminals and <z:mp ids='MP_0003354'>astrogliosis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>These results provide the first evidence that type 2 diabetic mice display a loss of nerve terminal markers and <z:mp ids='MP_0003354'>astrogliosis</z:mp>, which is associated with <z:hpo ids='HP_0002354'>memory impairment</z:hpo>; furthermore, <z:chebi fb="111" ids="27732">caffeine</z:chebi> consumption prevents synaptic dysfunction and <z:mp ids='MP_0003354'>astrogliosis</z:mp> as well as <z:hpo ids='HP_0002354'>memory impairment</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>